Clinical Trials
Clarity commences theranostic prostate cancer trial
Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...
July 29, 2021 | News
LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic
LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...
July 26, 2021 | News
Pfizer & BioNTech to manufacture and distribute covid-19 vaccine doses within Africa
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as &ldq...
July 22, 2021 | News
Novotech Joins (DTRA) to Accelerate Clinical Trials
The "Decentralized Trials & Research Alliance(DTRA)" ( https://www.dtra.org/ ), which was launched in December, 2020, is uniting in...
July 21, 2021 | News
Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio
Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...
July 20, 2021 | News
Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...
July 13, 2021 | News
I-Mab Expands Next Generation Novel Oncology Therapeutics
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...
July 10, 2021 | News
Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology
These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...
July 06, 2021 | News
Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...
July 01, 2021 | News
RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study
Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain ef...
June 29, 2021 | News
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...
June 23, 2021 | News
BIO to Hold First-Ever Clinical Trial Diversity Summit
The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on th...
June 22, 2021 | News
With Serum Institute as a partner, Novavax is poised to launch in India.
The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...
June 16, 2021 | News
Medidata to Offer Secure Platform for Decentralization of Clinical Trials
The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...
June 16, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
